Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
At a Glance A newly discovered protein marker on the surface of a retinal cell could help pave the way for cell therapies that restore vision in people with currently incurable forms of blindness. Research in the lab of Waisman investigator David Gamm, MD, PhD, professor of ophthalmology and visual sciences at the University of …
AT A GLANCE: Clinical trials serve as the crucial bridge between groundbreaking laboratory research and the eventual approval of new treatments or interventions. At the Waisman Center, researchers like Albee Messing, VMD, PhD, and David Gamm, MD, PhD have dedicated decades to transforming innovative ideas into potential therapies, now undergoing rigorous testing to ensure their …
Waisman Center investigator David Gamm, MD, PhD, is featured in a story from the Capital Times about research funding from the U.S. Department of Defense. Gamm is the director of the McPherson Eye Research Institute at UW-Madison. Read the full story here: https://captimes.com/news/education/uw-madison-wants-to-grow-defense-research-but-not-build-weapons/article_b7112c91-f754-454d-9b74-7f4e03a1178e.html
Outer retinal degenerative diseases (RDDs) and injuries leading to photoreceptor (PR) loss are prevailing causes of blindness worldwide.
There is no one “typical” type of researcher clinician. There are differences in training, percentage of focus on research vs clinic, and type of research done. Many also carry teaching and administrative responsibilities on top of their already demanding positions.
Age-related macular degeneration (AMD) causes blindness due to loss of retinal pigment epithelium (RPE) and photoreceptors (PRs), which comprise the two outermost layers of the retina.
Multiple discoveries born from the minds and hard work of Waisman Center investigators have left the nest to become successful companies or products that have had a significant impact in the world through translational research.
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new UW study, completing a “handshake” that may show the cells are ready for trials in humans with degenerative eye disorders.
David Gamm is adept at keeping multiple things in focus. Gamm, MD, PhD, is a Waisman investigator, director of the McPherson Eye Research Institute, and professor of ophthalmology and visual sciences. With one eye trained on patients, he treats children in the pediatric ophthalmology clinic.
